Germany lowers age threshold for mammography
Women aged 45 to 49 will gain access to the national screening programme from 2027.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
Germany is expanding its national mammography programme to women aged 45 to 49. Germany’s healthcare authority, the G-BA, took a decision on the matter on Thursday, but the new group is not expected to be able to make appointments themselves until August 2027.
The Gemeinsame Bundesausschuss, Germany’s federal committee that determines which healthcare is covered by statutory insurance, lowered the minimum age for the organised breast-screening programme on Thursday. Until now, women in Germany could take part from the age of 50; the upper age limit is 75.
The expansion will not be introduced immediately. Germany’s health minister must first review the decision legally. If no objection emerges, women aged 45 to 49 will be able to make appointments themselves through regional central bodies from 1 August 2027. Personal invitations are scheduled to be sent from January 2028.
According to the G-BA, this concerns around 2.5 million additional women. For the existing group aged 50 to 75, the committee says there are around 14.5 million potential participants. The screening programme is intended for people without symptoms or known abnormalities; anyone who does have symptoms falls outside the population screening programme and should seek medical help.
The committee says it weighed the benefits and possible disadvantages for the younger age group. Early detection can make breast-cancer treatment less intensive. The risks include false-positive results, follow-up tests and overdiagnosis: finding an abnormality that might never have caused symptoms during the person’s lifetime.
The age threshold is being adjusted after European guidelines advised including women aged 45 to 49 in organised screening. Germany’s radiation-protection rules were already amended in March, allowing the G-BA to take the reimbursement decision. Practical implementation still requires revised invitations, capacity at screening centres and new information materials.
The German decision is not a general medical recommendation for every woman. It concerns the design of a national screening programme and coverage through statutory insurance. The G-BA itself stresses that information about both the possible benefits and disadvantages must form part of the expansion.
Also show where in Europe and in the world
One story, several perspectives
What is established
- Germany is expanding the mammography programme covered by statutory insurance to women aged 45 to 49.
- Implementation is expected from August 2027, with invitations to follow later.
- Screening can result in both early detection and false-positive results and overdiagnosis.
Left
Arguments A public screening programme makes preventive care more accessible and prevents early detection from depending on income, insurance or assertiveness.
Values Equal access, collective healthcare and reducing health inequalities.
Consequences Higher participation may produce health benefits, but requires sufficient capacity and good support to limit anxiety and follow-up testing.
Centre
Arguments The age threshold should be determined by the balance between proven health benefits and possible harm. A phased introduction with clear information is therefore defensible.
Values Scientific evidence, informed choice and careful implementation.
Consequences The expansion may be justified if evaluation, quality and accessibility are monitored structurally.
Right
Arguments The government should be cautious about population screening of healthy people and leave room for individual choices and discussions with a doctor.
Values Personal responsibility, freedom of choice, efficiency and limiting government interference.
Consequences A broader scheme may lead to higher costs, follow-up tests and medical procedures without demonstrable benefit for every participant.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The decision and implementation dates were confirmed by the G-BA. The text presents benefits and risks as part of the assessment, not as personal advice.
- confirmed The G-BA lowered the age threshold to 45 on 15 October 2026. — This is stated in the official press release. source
- confirmed Self-referral is expected to be possible from 1 August 2027 and personal invitations from January 2028. — The G-BA explicitly names this transitional timetable. source
- confirmed Around 2.5 million women will gain additional access as a result of the expansion. — The figure comes from the G-BA’s explanatory notes. source
Editor's note
The decision, timetable and figures were directly confirmed by the G-BA. The article does not provide personal medical advice and mentions the disadvantages of screening.Sources
- Mammographie-Screening künftig auch für Frauen von 45 bis 49 Jahren — Gemeinsamer Bundesausschuss
- Mammographie-Screening: Ausweitung des Programms für Frauen im Alter von 45 bis 49 Jahren — Gemeinsamer Bundesausschuss
- Mammografie-Screening ab 45 Jahren — Deutsches Ärzteblatt
More on this in Dutch media
- NU.nl — „borstkanker mammografie”
- De Telegraaf — „borstkanker mammografie”
- AD — „borstkanker mammografie”